Skip to main content
. 2021 Jul 1;19:3908–3921. doi: 10.1016/j.csbj.2021.06.046

Fig. 1.

Fig. 1

Workflow for potential therapeutic drug repurposing for ASD. The workflow contains 4 main steps: a identification of NCGs based on network analysis methods; b drug repositioning with method 1: drug-target gene set enrichment analysis (dtGSEA); c drug repositioning with method 2: the Connectivity Map webtool; and d knowledge graph construction.